STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
163
13F, latest reported quarter
What the filings say about FRME
Insiders, 180 days
-$1.0M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$176.3K
1 notice
First Merchants insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, FIRST MERCHANTS CORP insiders sold a net $1.0M of stock across 40 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Jun 11, 2026.
The trade is 11.1% of the 89,751 shares held after it.
No other insider sold within 30 days.
163 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Myers Larry W sold about $420.0K of FRME on Jun 12, 2026, the largest insider sale at the company since 2024; 163 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 5, 2026.
The trade is 10.0% of the 99,751 shares held after it.
No other insider sold within 30 days.
163 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Myers Larry W sold about $415.0K of FRME on Jun 11, 2026, the largest insider sale at the company since 2024; 163 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 4.6% of the 109,491 shares held after it.
2 other insiders sold within 30 days.
163 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: First Vice President Myers Larry W sold about $207.5K of FRME on Feb 26, 2026, the largest insider sale at the company since 2024; 2 other insiders sold within 30 days and 163 funds added in the latest 13F quarter.
40 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
FRME planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Stephan H. Fluhler
Filed 2026-08-19
$176.3K
FRME mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Paradigm Value Fund
$1.2M position · as of 2026-06-30
2.2%
Nuveen Small Cap Value Fund
$5.4M position · as of 2026-07-31
1.9%
Harbor Small Cap Value Fund
$43.7M position · as of 2026-07-31
1.7%
RMB Mendon Financial Services Fund
$3.3M position · as of 2026-06-30
1.3%
Nuveen Small Cap Select Fund
$5.1M position · as of 2026-07-31
1.3%
VictoryShares US Small Cap High Div Volatility Wtd ETF
$3.1M position · as of 2026-06-30
1.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mark K. Hardwick
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$2.4M
$2.3M
$1.3M
+19%
+53%
2024
$2.1M
$2.2M
$1.2M
+14%
+30%
2023
$1.8M
$1.7M
$970.1K
+2%
+16%
2022
$1.9M
$1.8M
$1.0M
+8%
+16%
2021
$1.5M
$1.6M
$1.1M
+7%
+25%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.0M sold by insiders over 180 days, 163 funds added last quarter, $176.3K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM FRME
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM FRME
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM FRME
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity FRME
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt FRME
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+7.9%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on equity FRME
FY Dec 2025
+9.5%
FY Dec 2024
+8.8%
FY Dec 2023
+10.5%
FY Dec 2022
+11.3%
FY Dec 2021
n/a
Mar 2026
+7.9%
Dec 2025
+9.5%
Sep 2025
+9.9%
Jun 2025
+9.9%
Mar 2025
+9.2%
Dec 2024
+8.8%
Sep 2024
+8.2%
Jun 2024
+8.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.0%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets FRME
FY Dec 2025
+1.2%
FY Dec 2024
+1.1%
FY Dec 2023
+1.2%
FY Dec 2022
+1.3%
FY Dec 2021
n/a
Mar 2026
+1.0%
Dec 2025
+1.2%
Sep 2025
+1.3%
Jun 2025
+1.2%
Mar 2025
+1.1%
Dec 2024
+1.1%
Sep 2024
+1.0%
Jun 2024
+1.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital FRME
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed FRME
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.12x
close 2026-10-26 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing FRME
FY Dec 2025
9.66x
FY Dec 2024
11.66x
FY Dec 2023
9.94x
FY Dec 2022
10.79x
FY Dec 2021
10.99x
Mar 2026
11.42x
Dec 2025
9.66x
Sep 2025
9.43x
Jun 2025
9.92x
Mar 2025
11.36x
Dec 2024
11.66x
Sep 2024
12.32x
Jun 2024
10.67x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value FRME
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield FRME
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -5%, PEG needs growth
PEG, trailing FRME
FY Dec 2025
0.72x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.28x
Mar 2026
n/a
Dec 2025
0.72x
Sep 2025
0.29x
Jun 2025
0.42x
Mar 2025
3.93x
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
FRME ranks highest on institutional and government (71st percentile) and risk and compliance (41st), and lowest on insider conviction (14th), among Banks peers.
Profitability
35
Inputs
Return on equity+7.9% · 29 pct, sector of 327
Return on assets+1.0% · 41 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Insider conviction
14
Inputs
Net Form 4 buying (codes P and S), 180d-$1.0M · 27 pct, sector of 274
Insider buyers, 180d0 · 0 pct, sector of 274
Institutional and government
71
Inputs
Funds adding, latest quarter163 · 71 pct, sector of 257
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
41
Inputs
Short interest, % of float+4.0% · 41 pct, sector of 378
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Financial health, Growth, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
FRME filings, in plain words
Are First Merchants insiders buying or selling FRME?
In the 180 days to 2026-10-28, First Merchants insiders were net sellers, a net $1.0M across purchases and sales reported on Form 4, by 2 sellers.
Are there planned insider sales of FRME?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $176.3K of stock; the latest, by Stephan H. Fluhler, was filed 2026-08-19.
Read the full summary
In the 180 days to 2026-10-28, First Merchants insiders were net sellers of FRME, a net $1.0M across purchases and sales reported on Form 4 by 2 sellers. None of the 4 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $176.3K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.